Needham initiated coverage on Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) with 'buy' rating and $8 price target. The analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE